Evidence map›Paper›PMID 16945917›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Inhibition of a spliceosome turnover pathway suppresses splicing defects.

Shatakshi Pandit, Bert Lynn, Brian C Rymond

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shatakshi PanditDepartment of Biology, University of Kentucky, Lexington, KY 40506-0225, USA.
Bert Lynn
Brian C Rymond
University of Kentucky · US

Funding

FUNCTION OF SNRNP PARTICLES IN PREMRNA SPLICINGR01GM042476 · NIGMS · UNIVERSITY OF KENTUCKY · PI RYMOND, BRIAN C. · 1995 to 2007
$1.7M
FUNCTION OF SNRNP PARTICLES IN PRE-MRNA SPLICINGR29GM042476 · NIGMS · UNIVERSITY OF KENTUCKY · PI RYMOND, BRIAN C. · 1989 to 1993
–
NIGMS NIH HHS GM42476NIGMS NIH HHS R01 GM042476
6 · The paper itself

Abstract

Defects in assembly are suggested to signal the dissociation of faulty splicing complexes. A yeast genetic screen was performed to identify components of the putative discard pathway. Weak mutant alleles of SPP382 (also called NTR1) were found to suppress defects in two proteins required for spliceosome activation, Prp38p and Prp8p. Spp382p is shown necessary for cellular splicing, with premRNA and, for some alleles, excised intron, accumulating after inactivation. Like spp382-1, a mutant allele of AAR2 was identified in this suppressor screen. Like Spp382p, Aar2p has a reported role in spliceosome recycling and is found with Spp382p in a complex recovered with a mutant version of the spliceosomal core protein Prp8p. Possible insight into to the spp382 suppressor phenotype is provided by the observation that defective splicing complexes lacking the 5' exon cleavage intermediate are recovered by a tandem affinity purification-tagged Spp382 derivative. Stringent proteomic and two-hybrid analyses show that Spp382p also interacts with Cwc23p, a DNA J-like protein present in the spliceosome and copurified with the Prp43p DExD/H-box ATPase. Spp382p binds Prp43p and Prp43p requires Spp382p for intron release from the spliceosome. Consistent with a related function in the removal of defective complexes, three prp43 mutants are also shown to suppress splicing defects, with efficiencies inversely proportionate to the measured ATPase activities. These and related genetic data support the existence of a Spp382p-dependent turnover pathway acting on defective spliceosomes.

Indexed as

Suppression, GeneticAdenosine TriphosphatasesAllelesDEAD-box RNA HelicasesIntronsMutationNuclear ProteinsProtein Structure, TertiaryRNA HelicasesRNA SplicingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSpliceosomesAar2p protein, S cerevisiaeAdenosine TriphosphatasesDEAD-box RNA HelicasesNuclear ProteinsPRP43 protein, S cerevisiaeRNA HelicasesSaccharomyces cerevisiae ProteinsSpp382 protein, S cerevisiae

Identifiers

PMID16945917
PMCPMC1564266
OpenAlexW1967919168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.